Postnatal maturation of Sertoli cells is crucial for male fertility. The aim of this study was to assess the association between the Sertoli cell number per tubule cross-section (SC/T), the serum level of the Sertoli cell-produced inhibin B, and the A-dark spermatogonia number per tubule (Ad/T) in cryptorchid boys. Forty infant cryptorchid boys aged 4-35 months (median: 13 months) were included in the study. During orchiopexy, blood samples for serum inhibin B, luteinizing hormone (LH), and follicle stimulating hormone (FSH) and testicular biopsies were obtained. Histological sections were evaluated by quantitative immunohistochemical and immunofluorescence analysis including VASA and SOX9 (Sertoli cell marker) in order to measure the tubular germ cell number (G/T), Ad/T, and SC/T. The SC/T correlated negatively with age (p < 0.0002) and positively with G/T, Ad/T, inhibin B, FSH, and LH (all p < 0.01). Inhibin B correlated with LH (p < 0.0001), but not with FSH (p = 0.2077). The SC/T:G/T ratio positively correlated with age (p < 0.0001). Boys with Ad spermatogonia at surgery had a higher number of Sertoli cells compared to boys without Ad spermatogonia. In conclusion, a correlation between Sertoli cell number and inhibin B was proven, indicating that inhibin B possibly reflects the function of Sertoli cells in infant cryptorchid boys.

1.
Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, et al: Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 95:5357-5364 (2010).
2.
Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, et al: Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin Endocrinol Metab 81:3341-3345 (1996).
3.
Andersson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, et al: Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 83:675-681 (1998).
4.
Bergada I, Milani C, Bedecarras P, Andreone L, Ropelato MG, et al: Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 91:4092-4098 (2006).
5.
Berensztein EB, Baquedano MS, Gonzalez CR, Saraco NI, Rodriguez J, et al: Expression of aromatase, estrogen receptor alpha and beta, androgen receptor, and cytochrome P-450scc in the human early prepubertal testis. Pediatr Res 60:740-744 (2006).
6.
Bougneres P, Francois M, Pantalone L, Rodrigue D, Bouvattier C, et al: Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone. J Clin Endocrinol Metab 93:2202-2205 (2008).
7.
Boukari K, Meduri G, Brailly-Tabard S, Guibourdenche J, Ciampi ML, et al: Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Müllerian hormone repression during early human testis development. J Clin Endocrinol Metab 94:1818-1825 (2009).
8.
Chemes HE, Rey RA, Nistal M, Regadera J, Musse M, et al: Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab 93:4408-4412 (2008).
9.
Cortes D: Histological versus stereological methods applied at spermatogonia during normal human development. Scand J Urol Nephrol 24:11-15 (1990).
10.
Cortes D, Müller J, Skakkebaek NE: Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 10:589-596 (1987).
11.
Cortes D, Thorup J, Hogdall E, Norgaard-Pedersen B, Petersen BL, Hogdall C: The relation of germ cells per tubule in testes, serum inhibin B and FSH in cryptorchid boys. Pediatr Surg Int 23:163-169 (2007).
12.
Cortes D, Clasen-Linde E, Hutson JM, Li R, Thorup J: The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys. J Pediatr Surg 51:475-480 (2016).
13.
Crofton PM, Evans AEM, Groome NP, Taylor MRH, Holland CV, Kelnar CJH: Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocr 56:215-221 (2002).
14.
Gegenschatz-Schmid K, Verkauskas G, Demougin P, Bilius V, Dasevicius D, et al: Curative GnRHa treatment has an unexpected repressive effect on Sertoli cell specific genes. Basic Clin Androl 28:2 (2018).
15.
Hadziselimovic F, Herzog B: Importance of early postnatal germ cell maturation for fertility of cryptorchid males. Horm Res 55:6-10 (2001).
16.
Hadziselimovic F, Hocht B, Herzog B, Buser MW: Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res 68:46-52 (2007).
17.
Hamdi S, Almont MT, Galinier P, Mieusset R, Thonneau P: Altered secretion of Sertoli cells hormones in 2-year-old prepubertal cryptorchid boys: a cross-sectional study. Andrology 5:783-789 (2017).
18.
Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, Snyder HM: Abnormal germ cell development in cryptorchidism. Horm Res 55:11-17 (2001).
19.
Jorgensen N, Liu F, Andersson AM, Vierula M, Irvine DS, et al: Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: a coordinated study of 1,797 European and US men. Fertil Steril 94:2128-2134 (2010).
20.
Klingmüller D, Haidl G: Inhibin B in men with normal and disturbed spermatogenesis. Hum Reprod 12:2376-2378 (1997).
21.
Kollin C, Stukenborg JB, Nurmio M, Sundqvist E, Gustafsson T, et al: Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab 97:4588-4595 (2012).
22.
Kraft KH, Canning DA, Snyder HM, Kolon TF: Undescended testis histology correlation with adult hormone levels and semen analysis. J Urol 188:1429-1435 (2012).
23.
Li R, Azzollini D, Shen R, Thorup J, Clasen-Linde E, et al: Natural history of germ cell development in cryptorchid testes during first 18 months of life. J Pediatr Surg (2018, in press).
24.
Lim J, Goriely A, Turner GDH, Ewen KA, Jacobsen GK, et al: OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol 224:473-483 (2011).
25.
Main KM, Toppari J, Suomi AM, Kaleva M, Chellakooty M, et al: Larger testes and higher inhibin B levels in Finnish than in Danish newborn boys. J Clin Endocrinol Metab 91:2732-2737 (2006).
26.
Müller J, Skakkebaek NE: Fluctuations in the number of germ cells during the late foetal and early postnatal periods in boys. Acta Endocrinol 105:271-274 (1984).
27.
Orth JM, Gunsalus GL, Lamperti AA: Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology 122:787-794 (1988).
28.
Pierik FH, Deddens JA, Burdorf A, de Muinck Keizer-Schrama SM, Jong FH, Weber RF: The hypothalamus-pituitary-testis axis in boys during the first six months of life: a comparison of cryptorchidism and hypospadias cases with controls. Int J Androl 32: 453-461 (2009).
29.
Roosen-Runge EC, Barlow FD: Quantitative studies on human spermatogenesis. I. Spermatogonia. Am J Anat 93:143-169 (1953).
30.
Rune GM, Mayr J, Neugebauer H, Anders C, Sauer H: Pattern of Sertoli cell degeneration in cryptorchid prepubertal testes. Int J Androl 15:19-31 (1992).
31.
Sekido R, Lovell-Badge R: Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930-934 (2008).
32.
Sharpe RM, McKinnell C, Kivlin C, Fisher JS: Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:769-784 (2003).
33.
Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, et al: What is new in cryptorchidism and hypospadias-a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg 45:2074-2086 (2010).
34.
Thorup J, Petersen BL, Kvist K, Cortes D: Bilateral undescended testes classified according to preoperative and postoperative status of gonadotropins and inhibin B in relation to testicular histopathology at bilateral orchiopexy in infant boys. J Urol 188:1436-1442 (2012).
35.
Thorup J, Kvist K, Clasen-Linde E, Petersen BL, Cortes D: The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes. J Urol 190:1566-1571 (2013).
36.
Thorup J, Kvist K, Clasen-Linde E, Hutson JM, Cortes D: Serum inhibin B values in boys with unilateral vanished testis or unilateral cryptorchidism. J Urol 193:1632-1636 (2015a).
37.
Thorup J, Clasen-Linde E, Thorup SC, Cortes D: Pre- and postoperative status of gonadotropins (FSH and LH) and inhibin-B in relation to testicular histopathology at orchiopexy in infant boys with unilateral undescended testes. J Pediatr Urol 11:25.e21-25 (2015b).
38.
Thorup J, Clasen-Linde E, Li R, Reinhardt S, Kvist K, et al: Postnatal germ cell development in the cryptorchid testis: the key to explain why early surgery decreases the risk of malignancy. Eur J Pediatr Surg 28:469-476 (2017).
39.
Verkauskas G, Malcius D, Eidukaite A, Vilimas J, Dasevicius D, et al: Prospective study of histological and endocrine parameters of gonadal function in boys with cryptorchidism. J Pediatr Urol 12:238.e231-236 (2016).
40.
Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G: Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J Clin Endocrinol Metab 85:3239-3244 (2000).
41.
Zivkovic D, Hadziselimovic F: Development of Sertoli cells during mini-puberty in normal and cryptorchid testes. Urol Int 82:89-91 (2009).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.